Abstract
Rats were trained to self-administer nicotine on a fixed-ratio schedule of reinforcement. Infusion of the nicotinic antagonist chlorisondamine into the cerebral ventricles produced a sustained reduction in nicotine self-administration compared to vehicle-treated controls. Lesions of the mesolimbic dopamine system were produced by microinfusion of 6-hydroxydopamine into the nucleus accumbens. Following production of the lesions, nicotine self-administration was markedly reduced for the 3-week test period; motor impairment did not appear to be responsible. Post mortem analysis of brain tissue showed that the lesion produced a pronounced decrease in dopamine content of the nucleus accumbens and the olfactory tubercle, and a small depletion in the striatum. These data demonstrate that the reinforcing effects of nicotine occur within the central nervous system, and that the mesolimbic dopamine projection plays an important role in these effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Calabresi P, Lacey MG, North RA (1989) Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98:135–140
Clarke PBS (1984) Chronic nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine. Br J Pharmacol 83:527–535
Clarke PBS (1991) Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 86:501–505
Clarke PBS, Kumar R (1983) Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br J Pharmacol 80:587–594
Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355–358
Clarke PBS, Fu DS, Jakubovic A, Fibiger HC (1988a) Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther 246:701–708
Clarke PBS, Jakubovic A, Fibiger HC (1988b) Anatomical analysis of the involvement of mesolimbic dopamine in the locomotor stimulant actions ofd-amphetamine and apomorphine. Psychopharmacology 96:511–520
Clarke PBS, Chaudrieu I, Boksa P, Capek R (1990) The pharmacology of chlorisondamine investigated in rat brain. Soc Neurosci Abstr 16:420
Corrigall WA (1991a) Understanding brain mechanisms in nicotine reinforcement. Br J Addict 86:507–510
Corrigall WA (1991b) A rodent model for nicotine self-administration. In: Boulton AA, Baker GB, Wu PH (eds) Animal models of drug addiction. Neuromethods, vol 21. Humana Press, Clifton, NJ (in press)
Corrigall WA (1991c) Regulation of intravenous nicotine self-administration — dopamine mechanisms. In: Adlkofer F, Thurau K (eds) Effects of nicotine on biological systems. Birkhauser, Basel
Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99:473–478
Corrigall WA, Coen KM (1991) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104:171–176
Deutsch AY, Holliday J, Roth RH, Chun LLY, Hawrot E (1987) Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc Natl Acad Sci USA 84:8697–8701
Goldberg SR, Spealman RD, Goldberg DM (1981) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214:573–575
Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1–12
Imperato A, Mulus A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine released in the limbic system of freely moving rats. Eur J Pharmacol 132:337–338
Izenwasser S, Jacocks HM, Rosenberger JG, Cox BM (1991) Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum. J Neurochem 56:603–610
Kelly H, Iversen SD (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45–56
Kumar R, Reavill C, Stolerman IP (1987) Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br J Pharmacol 90:239–246
Martin-Iverson MT, Szostak C, Fibiger HC (1986) 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacology 88:310–314
Mifsud JC, Hernandez L, Hoebel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365–367
Museo E, Wise RA (1990a) Locomotion induced by ventral tegmental microinjections of a nicotinic agonist. Pharmacol Biochem Behav 35:735–737
Museo E, Wise RA (1990b) Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion. Pharmacol Biochem Behav 37:113–116
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
Pettit HO, Ettenberg E, Bloom FE, Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167–173
Reavill C, Stolerman IP (1990) Locomotor activity in rats after administration of nicotine agonists locally. Br J Pharmacol 99:273–278
Reavill C, Stolerman IP, Kumar R, Garcha HS (1986) Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (−)-nicotine. Neuropharmacology 25:1067–1069
Risner ME, Goldberg SR (1983) A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther 224:319–326
Roberts DCS, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781–787
Romano C (1981) Nicotine action on rat colon. J Pharmacol Exp Ther 217:828–833
Romano C, Goldstein A (1980) Stereospecific nicotine receptors on rat brain membranes. Science 210:647–650
Spealman RD, Goldberg SR (1982) Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402–408
Swanson LW, Simmons DM, Whiting PJ, Lindstrom J (1987) Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci 7:3334–3342
Tennant FS, Tarver AL, Rawson RA (1984) Clinical evaluation of mecamylamine for withdrawal from nicotine dependence. NIDA Res Monogr 49:239–246
US DHHS (1988) The health consequences of smoking: nicotine addiction. A report of the Surgeon General. US Dept of Health and Human Services, Rockville, MD
Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW (1989) Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284:314–335
White NM (1988) Effects of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine. Life Sci 43:7–12
Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Corrigall, W.A., Franklin, K.B.J., Coen, K.M. et al. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107, 285–289 (1992). https://doi.org/10.1007/BF02245149
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245149